| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net loss | -1,265,394 | -209,782 | -32,252 | -129,649 |
| Depreciation and amortization | 41,359 | 17,177 | 6,561 | 13,150 |
| Non-cash research and development arrangements | - | - | - | 390 |
| Stock-based compensation | 205,366 | 132,421 | 33,253 | 67,607 |
| (gain) loss on change in fair value of warrant liabilities | 882,930 | 1,083 | -38,494 | -11,398 |
| Deferred income taxes | -19,885 | -15,300 | - | - |
| Amortization of premiums and accretion of discounts on available-for-sale securities | 6,167 | 3,540 | 1,409 | 7,086 |
| Other, net | -5,872 | -1,502 | -825 | -3,901 |
| Accounts receivable | 15,849 | 3,595 | -748 | -7,341 |
| Prepaid expenses and other current assets | 42,572 | 25,142 | 12,471 | 9,899 |
| Accounts payable | -17,413 | 1,094 | 3,272 | -463 |
| Accrued expenses and other current liabilities | 27,777 | 20,741 | 6,123 | 612 |
| Unearned revenue | 268 | -4 | 1,299 | -4,232 |
| Other assets and liabilities | 4,969 | 2,254 | 480 | -3,471 |
| Net cash provided by (used in) operating activities | -208,677 | -85,599 | -33,025 | -66,255 |
| Purchases of property and equipment | 7,628 | 3,501 | 2,308 | 14,399 |
| Capitalized software development costs | 2,961 | 1,886 | 882 | 3,064 |
| Intangible asset acquisition costs | - | 307 | 220 | 1,201 |
| Purchases of available-for-sale securities | 1,252,367 | 435,130 | 320,571 | 241,162 |
| Maturities of available-for-sale securities | 407,730 | 211,180 | 93,805 | 318,192 |
| Businesses acquired, net of cash acquired | 13,100 | -28,667 | - | - |
| Other investing, net | 5,306 | - | - | - |
| Net cash provided by (used in) investing activities | -873,632 | -200,977 | -230,176 | 58,366 |
| Proceeds from at-the-market offering, net of issuance costs | - | 358,254 | 362,303 | - |
| Proceeds from common stock and warrant issuance, net of issuance costs | 1,358,254 | - | - | - |
| Proceeds from stock options exercised | 11,468 | 7,564 | 1,213 | 2,270 |
| Proceeds from warrants exercised | 6,708 | 5,592 | 4,702 | - |
| Tax withholding receipts (payments) related to vested and released rsus, net | - | 1,447 | 516 | - |
| Other financing, net | 986 | - | - | 144 |
| Net cash provided by (used in) financing activities | 1,377,416 | 372,857 | 368,734 | 2,414 |
| Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | 375 | 391 | -13 | 4 |
| Net change in cash, cash equivalents and restricted cash | 295,482 | 86,672 | 105,520 | -5,471 |
| Cash and cash equivalents at beginning of period | 56,840 | 56,840 | 56,840 | 38,081 |
| Cash and cash equivalents at end of period | 352,322 | 143,512 | 162,360 | 32,610 |
IonQ, Inc. (IONQ)
IonQ, Inc. (IONQ)